Connect with us


Drug found to slow Alzheimer’s by up to 60 percent in trial



A new drug has been hailed as a “breakthrough” after it was found to slow the progression of Alzheimer’s disease by 60 percent if started when patients are in the earliest stages of the brain-wasting disease, according to a new study.

The drug, donanemab, has been shown to slow progression of memory and thinking problems by about a third, but that rate doubles to 60 percent if the drug is started when patients are only mildly impaired, according to new trial data presented by Eli Lilly on Monday at the Alzheimer’s Association International Conference in Amsterdam.

The full analysis presented by the American pharmaceutical company showed results were less robust for older, later-stage patients as well as those with higher levels of a protein called tau, which has been linked to Alzheimer’s disease progression.

The findings underscored that “earlier detection and diagnosis can really change the trajectory of this disease”, Anne White, president of neuroscience at Eli Lilly, told the Reuters news agency.


The drug consists of injecting donanemab, an intravenous antibody designed to remove deposits of a protein called beta amyloid from the brains of Alzheimer’s patients.

Donanemab’s treatment effect continued to increase relative to placebos over the course of the 18-month trial, even for participants who had been taken off the drug after their levels of amyloid deposits fell significantly.

“At the end of the trial, the average patient had been without the drug for seven months, and yet they continued to benefit,” White said.

The company expected the US Food and Drug Administration to decide by the end of this year whether to approve donanemab. It said submissions to other global regulators were under way and most will be completed by year’s end.

More than 55 million people worldwide are affected by dementia, and the number is projected to rise to 139 million people by 2050, according to Alzheimer’s Disease International, the worldwide federation of Alzheimer’s associations.

The new medication has been welcomed with enthusiasm by patients. Joe Montminy, who was diagnosed with early onset Alzheimer’s disease at 54, said the disease has kept “changing the core of who I am” over the past six years.

“Everyday things like projects around the house or something as simple as texting now take me two to three times longer than they did just six months ago,” Montminy told Al Jazeera.

His wife and mother noticed changes in his personality, including mood swings, impulsiveness and a short temper, which he says are “out of character”.

“I’m very excited about having these new treatments because getting six months, nine months or more quality time with my wife, my sons and my friends would be priceless,” Montminy said.

Side effects

Al Jazeera’s Step Vaessen, reporting from Amsterdam, said the findings have been hailed as a “breakthrough” at the conference but “real division” remains within the scientific community.

The full analysis also highlighted side effects including brain swelling. Brain bleeding occurred in 31 percent of the donanemab group and about 14 percent of the placebo group.

The deaths of three trial patients were linked to the treatment, researchers reported.

“Scientists I spoke to who are not here at the conference say that [the drug] is too driven by the pharmaceutical industry,” she said. “Big pharma is pushing for a new medicine because it’s a huge group of patients they are targeting.”

An additional downside was the cost of the medication. “It is estimated that it’s going to cost around $26,000 per patient per year,” Vaessen said.

More than 6 million Americans are living with Alzheimer’s, and that number is projected to rise to nearly 13 million by 2050, according to the Alzheimer’s Association.

Another recently approved drug, Leqembi from Japanese drugmaker Eisai, also comes with serious safety concerns, including brain swelling and bleeding.

Scientists said that while these drugs may mark a new era in Alzheimer’s therapy, huge questions remain about which patients should try them and how much benefit they will really notice.



Source link

Continue Reading


The Key Role of Trustworthy Babysitters in Balancing Work and Family Life




Are you a busy parent in constant pursuit of the elusive work-life balance? We know firsthand how overwhelming and challenging it can be to juggle professional commitments while still having quality time with your children.

That’s why we’re here to discuss an essential ingredient that unlocks the secret to harmony: trustworthy babysitters.

What Characteristics Parents Should Look for When Choosing a Babysitter?

Parents should look for a few key characteristics when choosing a babysitter. A good babysitter should be patient, responsible, and reliable. They should also be comfortable with children and have prior experience caring for them.

Besides, the babysitter must be able to communicate effectively and follow directions well. The babysitter should be someone the parents can trust to care for their children in their absence.


Strategies for Parents to Establish Reasonable Anticipations

As a parent, finding babysitters you can trust to care for your children is vital. However, it is also important to establish reasonable expectations for your babysitters.

Some tips for establishing reasonable expectations for babysitters include:

  1. Set clear expectations: Sit down with your babysitter to discuss bedtime routines, dietary preferences, and any necessary medications.
  2. Allow flexibility: While clarity is vital, also provide room for your babysitter to use their judgment and feel comfortable in their role.
  3. Trust their expertise: Once expectations are set, trust your babysitter’s judgment as a professional caregiver to avoid undermining their authority and creating discomfort in their role.

Determining a Fair Payment Plan

Determine your babysitting budget, factoring in your income and family size, while researching local rates. Account for the babysitter’s experience and qualifications, giving preference to those recommended by trusted sources.

Engage in open negotiations with your chosen babysitter. This aims to find a mutually agreeable arrangement that accommodates both your budget and their needs.

Tips on Finding Trustworthy and Compassionate Caregivers

When seeking a caregiver for your child, to ensure you find the right fit:

  • Seek recommendations from trusted sources such as friends, family, and neighbours who may have suggestions for caregivers in your area.
  • Conduct online research to review feedback and check references to gauge candidates’ qualifications and experience.
  • Request references and contact details from the caregivers’ previous employers or families they have worked with.
  • Trust your instincts and ensure you feel at ease with the caregiver, ensuring they are someone you can entrust with your child’s well-being.


Being able to trust your babysitter means you can have peace of mind knowing your child is safe and cared for.

Spending some time researching online reviews or asking friends and family for recommendations will help you find the perfect fit so you can feel more at ease while juggling work commitments in today’s hectic world.

Continue Reading


Facility-wide COVID-19 outbreak at Bethammi Nursing Home



THUNDER BAY — St. Joseph’s Care Group and the Thunder Bay District Health Unit have declared a facility-wide COVID-19 outbreak at Bethammi Nursing Home, part of the St. Joseph’s Heritage complex on Carrie Street near Red River Road.

The respiratory outbreak at the 112-bed facility was declared effective Sept. 15 but only announced publicly on Monday.

No details were provided with regard to the number of people affected to date.

Restrictions are now in place for admissions, transfers, discharges, social activities and visitation until further notice.




Source link

Continue Reading


Alberta COVID hospitalizations up 73% since July: health minister



Three weeks after the start of the school year, Alberta’s health minister provided an update on the spread of airborne viruses in the province.

Adriana LaGrange also said more information about flu and next-generation COVID-19 vaccines will soon be released.

“Now that we will be spending more time indoors, we need to make doubly sure we are following proper hygiene protocols like handwashing and staying home when sick,” LaGrange said. “It also means respecting those who choose to wear a mask.”


Global News previously reported that influenza vaccines will be available on Oct. 16 with the new Moderna vaccine formulated to target the XBB.1.5 variant likely to be available at around the same time. On Sept. 12, Health Canada approved the use of the Moderna vaccine.

“More information on immunizations against respiratory viruses including influenza and COVID-19 will be available shortly,” the health minister said.

LaGrange said there have been 28 cases of influenza and five lab-confirmed cases of respiratory syncytial virus (RSV) since Aug. 28.

“This is consistent activity for this time of the year,” the health minister said in a statement.

The end of August or the beginning of September has typically marked the beginning of flu season for provincial health authorities.

LaGrange also provided an update on the ongoing COVID-19 pandemic in the province.

From Aug. 28 to Sept. 8, there were a total 92 new hospitalizations and three ICU admissions, bringing the total to 417 in hospital and seven in ICU, a 73 per cent increase of COVID hospitalizations from the last reported info.

On July 24 – the last update to the province’s COVID data dashboard – there were only 242 in hospital.

“Sadly, five Albertans died during that period due to COVID-19,” LaGrange said.

LaGrange said the reporting dashboard is being refreshed to include RSV, influenza and COVID-19 data, work that was originally expected to be completed on Aug. 30. The latest data on the province’s influenza statistics dashboard is dated July 22.

“This work is currently underway and will be available in the coming weeks,” LaGrange said.

She said data for the dates between July 24 and Aug. 27 will be available when the new dashboard goes online.

Amid more hospitals continent-wide reinstating masking requirements in the face of increased hospitalizations, the health minister made no mention of any such moves for Alberta hospitals. Acute care COVID-19 outbreaks in Alberta jumped from Sept. 5 to 12, with 146 per cent more healthcare workers and 55 per cent more patients testing positive for COVID.

LaGrange stressed the “collective responsibility” to prevent the spread of airborne viruses like COVID and influenza.

“As a mother and grandmother, I understand the anxiety that comes with sending your children back to school. I want to reassure you that Alberta’s government has the health and well-being of all young Albertans top of mind,” the health minister said.

–with files from Meghan Cobb, Global News



Source link

Continue Reading